Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sickle Cell Disease Patient Reported Outcomes in Adult Participants Aged ≥18 Years of Age On and Off Hydroxyurea

NCT06503458 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.

NCT NCT06503458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sickle Cell Disease Patient Reported Outcomes in Adult Participants Aged ≥18 Years of Age On and Off Hydroxyurea
Lead sponsor
Sanguine Biosciences
Phase
Observational
Overall status
Terminated
Start date
January 19, 2022
Completion date
April 10, 2024
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia, sickle cell disease